Sentence examples for mutant exhibited comparable from inspiring English sources
We observed that SH5190 and the R292K mutant exhibited comparable sensitivity to T-705 (IC50 values of 3.10 µM and 6.26 µM, respectively) and ribavirin (IC50 values of 3.32 µM and 7.43 µM, respectively).
All ERA mutant preparations were more cytopathogenic than the parental virus when propagated in cell culture; when in vivo pathogenicity in mice was examined, three of these mutants exhibited reduced pathogenicity while the remaining four mutants exhibited comparable pathogenic properties to those of the parent virus.
The Col vim1 null mutants exhibit comparable DNA methylation to the standard wild-type Col strain in 45S rRNA gene repeats.
While all mutant strains exhibited comparable growth patterns, the S. coelicolor Δ wblAΔSCO1712ΔSCO5426 triple knock-out mutant strain exhibited the highest actinorhodin productivity, which was 1.7-fold and 1.3-fold higher than those of the single knock-out S. coelicolor Δ wblA and the double knock-out S. coelicolor Δ wblAΔSCO1712 mutant strains, respectively [ 42].
No aerobic growth defect was seen for the Δ narG mutant, which exhibited comparable aerobic growth rates to that of the wild type in both M9 minimal medium and L broth (see Fig. S9C and E in the supplemental material).
These observations are unlikely to be due to differences in senescence rates between Aptx−/− SOD1 G93A double mutants and SOD1 G93A single mutants since they both exhibited comparable senescence (Supplementary Material, Fig. S1).
Cells expressing either the wild-type AC2 or the T1057A mutant exhibited a comparable and rapid enhancement in cAMP in response to CCh.
The mutant and control mice exhibited comparable performances in quadrant occupancy (Figure 5E), target quadrant occupancy (Figure 5F), and the number of platform crossings (Figure 5G).
Most synthesized compounds exhibited comparable efficacy to ticlopidine and clopidogrel.
In particular, 11a exhibited comparable potency with that of Imatinib.
Interestingly, many compounds exhibited comparable VEGFR-2 inhibition to Sorafenib.
